COMP <GO>
SABS vs ALEC // EV/EBITDA & P/E VALUATION
SAB Biotherapeutics Inc. (NASDAQ) VS. Alector Inc. (NASDAQ) • 15-METRIC TALLY: SABS 3
— ALEC 2
■ METRIC PARITY
LAST: $3.30 (-1.49%) • MKT CAP: $304.8M
valuation
—
LAST: $2.15 (-2.71%) • MKT CAP: $327.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SABS VS. ALEC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SABS | ALEC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.40% | -35.00% | +7.60 | SABS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.55% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -65.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.07 | 0.20 | +6.87 | SABS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | SABS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.0 | 59.7 | -0.70 | ALEC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $304.8M | $327.6M | -$22.8M | ALEC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SABS REV | ALEC REV | SABS GROSS % | ALEC GROSS % | SABS FCF | ALEC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $137.1M | $21.0M | — | — | -$45.7M | -$184.1M |
| FY 2024 | $1.3M | $100.6M | — | — | -$34.6M | -$231.2M |
| FY 2023 | $2.2M | $97.1M | — | — | -$25.1M | -$184.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SABS // BETA —
ALEC // BETA —